These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26275302)

  • 1. Measuring Health Utilities in Children and Adolescents: A Systematic Review of the Literature.
    Thorrington D; Eames K
    PLoS One; 2015; 10(8):e0135672. PubMed ID: 26275302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?
    Ungar WJ
    Pharmacoeconomics; 2011 Aug; 29(8):641-52. PubMed ID: 21604821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of health utilities across conditions common in paediatric and adult populations.
    Tarride JE; Burke N; Bischof M; Hopkins RB; Goeree L; Campbell K; Xie F; O'Reilly D; Goeree R
    Health Qual Life Outcomes; 2010 Jan; 8():12. PubMed ID: 20105304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review.
    Räsänen P; Roine E; Sintonen H; Semberg-Konttinen V; Ryynänen OP; Roine R
    Int J Technol Assess Health Care; 2006; 22(2):235-41. PubMed ID: 16571199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of classic utilities to published pediatric cost-utility studies.
    Finnell SM; Carroll AE; Downs SM
    Acad Pediatr; 2012; 12(3):219-28. PubMed ID: 22075466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the measurement of health utilities in published cost-utility analyses.
    Brauer CA; Rosen AB; Greenberg D; Neumann PJ
    Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mind the (inter-rater) gap. An investigation of self-reported versus proxy-reported assessments in the derivation of childhood utility values for economic evaluation: A systematic review.
    Khadka J; Kwon J; Petrou S; Lancsar E; Ratcliffe J
    Soc Sci Med; 2019 Nov; 240():112543. PubMed ID: 31586777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review and Meta-analysis of Childhood Health Utilities.
    Kwon J; Kim SW; Ungar WJ; Tsiplova K; Madan J; Petrou S
    Med Decis Making; 2018 Apr; 38(3):277-305. PubMed ID: 28990449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease.
    Zhou T; Chen Z; Li H; Xie F
    Med Decis Making; 2021 Aug; 41(6):685-692. PubMed ID: 33813938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation.
    Ruchlin HS; Insinga RP
    Pharmacoeconomics; 2008; 26(11):925-35. PubMed ID: 18850762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should "standard gamble" and "'time trade off" utility measurement be used more in mental health research?
    Flood C
    J Ment Health Policy Econ; 2010 Jun; 13(2):65-72. PubMed ID: 20919593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of the impact of urinary tract infections on health-related quality of life.
    Bermingham SL; Ashe JF
    BJU Int; 2012 Dec; 110(11 Pt C):E830-6. PubMed ID: 22816657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review.
    Herdman M; Cole A; Hoyle CK; Coles V; Carroll S; Devlin N
    Value Health; 2016; 19(2):255-66. PubMed ID: 27021761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of different scenarios for intermittent bladder catheterization on health state utilities: results from an internet-based time trade-off survey.
    Averbeck MA; Krassioukov A; Thiruchelvam N; Madersbacher H; Bøgelund M; Igawa Y
    J Med Econ; 2018 Oct; 21(10):945-952. PubMed ID: 29882712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods and issues associated with the use of quality-adjusted life-years.
    Revicki DA; Lenderking WR
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):105-14. PubMed ID: 22280200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-state utilities in liver disease: a systematic review.
    McLernon DJ; Dillon J; Donnan PT
    Med Decis Making; 2008; 28(4):582-92. PubMed ID: 18424560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What PASSes for good? Experience-based Swedish and hypothetical British EuroQol 5-Dimensions preference sets yield markedly different point estimates and patient acceptable symptom state cut-off values in chronic arthritis patients on TNF blockade.
    Cooper A; Wallman JK; Gülfe A
    Scand J Rheumatol; 2016 Nov; 45(6):470-473. PubMed ID: 27025702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data.
    Reddy BP; Adams R; Walsh C; Barry M; Kind P
    Value Health; 2015 Sep; 18(6):841-5. PubMed ID: 26409612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.